Systemic therapy stands as a cornerstone in contemporary cancer treatment, representing a holistic approach that targets cancer cells throughout the body. This modality encompasses chemotherapy, targeted therapy, immunotherapy, and hormone therapy, each tailored to disrupt cancer's growth and spread. Chemotherapy employs cytotoxic drugs to eradicate rapidly dividing cancer cells, while targeted therapy zeroes in on specific molecular alterations driving cancer progression. Immunotherapy harnesses the body's immune system to recognize and destroy cancer cells, while hormone therapy interferes with hormone signaling pathways crucial for certain cancers, like breast and prostate cancer. These systemic approaches not only combat primary tumors but also address metastatic disease, enhancing survival rates and improving patients' quality of life. As cancer research continues to unveil novel therapeutic targets, systemic therapies remain pivotal in the evolving landscape of oncology.



Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States
Title : Graphene quantum dots: A new frontier for photodynamic therapy
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil